Edwards Lifesciences Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio10.4632.9830.3153.8169.05
Forward P/E31.1928.4130.3552.9843.34
P/S Ratio8.039.2310.3315.4612.96
P/B Ratio4.346.887.9413.8612.43
Price/Tangible Book6.209.0610.5918.6218.52
Price/FCF150.6171.9447.3857.5187.84
Price/OCF80.5151.6337.8746.7053.93
PEG Ratio3.692.772.953.383.13
Enterprise Value Ratios
EV/Revenue7.359.0110.1015.2412.82
EV/EBITDA24.4427.6626.8146.3439.52
EV/EBIT27.0030.3529.2450.2842.74
EV/FCF137.9270.2346.3056.7386.91
Profitability & Returns
Return on Equity (ROE)0.17%0.19%0.23%0.29%0.19%
Return on Assets (ROA)0.08%0.11%0.11%0.13%0.12%
Return on Invested Capital (ROIC)0.21%0.24%0.26%0.31%0.33%
Return on Capital Employed (ROCE)0.13%0.18%0.21%0.21%0.21%
Leverage & Solvency Ratios
Debt/Equity0.070.100.120.120.15
Debt/EBITDA0.420.410.410.390.48
Debt/FCF2.421.070.710.491.07
Liquidity Ratios
Current Ratio4.183.383.033.083.46
Quick Ratio3.132.061.872.062.24
Efficiency Ratios
Asset Turnover0.480.570.530.670.64
Inventory Turnover1.121.100.901.631.50
Yield & Distribution Ratios
Earnings Yield0.10%0.03%0.03%0.02%0.01%
FCF Yield0.01%0.01%0.02%0.02%0.01%
Buyback Yield0.02%0.02%0.01%0.00%0.01%